While we observed a numerical trend in 90-day survival of patients with Impella support, our study was not powered to detect a mortality difference.
← all excerpts
Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
1
—
—